Home Drug Codes J Codes J9260 · METHOTREXATE
Updated July 1st, 2026

METHOTREXATE J Code: J9260

Injection, methotrexate sodium, 50 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9260, effective October 1, 2026: $2.909 per HCPCS billing unit, down 1.1% from $2.941. From CMS's final file.

?
Medicare Payment Limit ?
$2.941
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
19
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, methotrexate sodium, 50 mg
HCPCS Added Date January 1, 1984
Manufacturer Multiple Manufacturers
Route of Administration Intra-Arterial, Intramuscular, Intrathecal, Intravenous, Subcutaneous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose, Multi-Dose
Dosage Form Injection | Injection, Powder, Lyophilized, For Solution | Injection, Solution | Not Available | Solution

About METHOTREXATE

Methotrexate is a medication aligned to the HCPCS J Code: J9260 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intra-arterial, intramuscular, intrathecal, intravenous, or subcutaneous routes and manufactured by multiple companies.

According to CMS Drug Use Information: Methotrexate is used to treat certain types of cancer, severe psoriasis, or rheumatoid arthritis. It may also be used to treat a certain type of arthritis in children (polyarticular juvenile idiopathic arthritis - pJIA). Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and blocking the immune system from attacking healthy tissue. Early treatment of rheumatoid arthritis with methotrexate helps to reduce further joint damage and to preserve joint function.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 19 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9367-01 Methotrexate Hikma Pharmaceuticals USA Inc. 20 Methotrexate Intra-Art erial Injection … Login for More
00703-3671-01 Methotrexate Teva Parenteral Medicines, Inc. 1 50 MG / 2 ML
16729-0277-30 Methotrexate Accord Healthcare, Inc. 1 50 MG / 2 ML
61703-0124-40 Methotrexate Hospira, Inc. 20 1000 MG / 40 ML
63323-0122-50 Methotrexate Fresenius Kabi USA, LLC 20 Methotrexate Intra-Art erial Injection … Login for More
•••••-••••-•• Log in to view METHOTREXATE
METHOTREXATE
METHOTREXATE
Login to view 14 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

METHOTREXATE Pricing & Reimbursement

J9260 Private Payer Reimbursement
$2.60 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

METHOTREXATE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
96401 Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96409 Login for More Chemotherapy administration; intravenous, push technique, single or initial substance/drug Login for More
96413 Login for More Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug Login for More
96415 Login for More Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More
Not on the CMS JW / JZ list

CMS does not include Methotrexate (J9260) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9260. Wastage billing guide →

METHOTREXATE Medically Unlikely Edits (MUE)

The most billing units of J9260 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 50 mg.

Practitioner Office & Hospital Outpatient
400 units / day
= 20,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

METHOTREXATE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute Lymphoblastic Leukemia Acute lymphoblastic leukemia Breast Cancer Burkitt's Tumor (Non-Hodgkin's Lymphoma) Burkitt's tumor (Non-Hodgkin's lymphoma) Choriocarcinoma and Similar Trophoblastic Diseases Choriocarcinoma and similar trophoblastic diseases Epidermoid Cancers of the Head and Neck Gestational Trophoblastic Neoplasia Lung Cancer Lymphosarcoma (Non-Hodgkin's Lymphoma) Meningeal Leukemia Meningeal leukemia Mycosis Fungoides (Cutaneous T Cell Lymphoma) Mycosis fungoides (cutaneous T cell lymphoma) Non-Hodgkin Lymphoma Non-Hodgkin's Lymphomas (advanced stage) Osteosarcoma Polyarticular Juvenile Idiopathic Arthritis Polyarticular-Course Juvenile Rheumatoid Arthritis Polyarticular-course juvenile rheumatoid arthritis Psoriasis Rheumatoid Arthritis Rheumatoid arthritis Squamous Cell Carcinoma of the Head and Neck
Drug Class
Folate Analog Metabolic Inhibitor [EPC]Folic Acid Metabolism Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Methotrexate billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for METHOTREXATE.
Are there any available Methotrexate patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for METHOTREXATE.
Where can I find Methotrexate prescribing information?
METHOTREXATE prescribing information can be found at the link below: Visit Here →
Where can I find Methotrexate side effect information?
Information regarding METHOTREXATE's side effects can be found at MedlinePlus Visit Here →
Does billing METHOTREXATE require JZ/JW wastage modifiers?
CMS does not include METHOTREXATE (J9260) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9260. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.